Financials

  • Market Capitalization 539.02 M
  • Employee 23
  • Founded 2014
  • CEO N/A
  • Website www.ovidrx.com
  • Headquarter Delaware, United States
  • FIGI BBG009F0TD76
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.81
Relación precio/flujo de caja
168.21

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2860
ZURA
Zura Bio Limited - Class A Ordinary shares
5.65 USD+1.99%-7.83%+3.48%+176.96%541.43 M USD
2863
DRUG
Bright Minds Biosciences Inc. - common stock
70.84 USD-1.24%-11.16%-3.41%+80.25%540.92 M USD
2892
KYTX
Kyverna Therapeutics, Inc. - Common Stock
8.35 USD-1.53%-5.22%+15.17%+135.21%516.39 M USD
2903
ENTX
Entera Bio Ltd. - Ordinary Shares
2.90 USD-1.69%-16.18%-0.34%+44.28%502.11 M USD

Noticias